These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

799 related items for PubMed ID: 24879937

  • 1. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan.
    Sepehri N, Rouhani H, Tavassolian F, Montazeri H, Khoshayand MR, Ghahremani MH, Ostad SN, Atyabi F, Dinarvand R.
    Int J Pharm; 2014 Aug 25; 471(1-2):485-97. PubMed ID: 24879937
    [Abstract] [Full Text] [Related]

  • 2. Lipid nanoparticles loaded with 7-ethyl-10-hydroxycamptothecin-phospholipid complex: in vitro and in vivo studies.
    Liu H, Lu H, Liao L, Zhang X, Gong T, Zhang Z.
    Drug Deliv; 2015 Aug 25; 22(6):701-9. PubMed ID: 24625262
    [Abstract] [Full Text] [Related]

  • 3. SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study.
    Fang YP, Chuang CH, Wu YJ, Lin HC, Lu YC.
    Int J Nanomedicine; 2018 Aug 25; 13():2789-2802. PubMed ID: 29785106
    [Abstract] [Full Text] [Related]

  • 4. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.
    Wang Y, Guo M, Lu Y, Ding LY, Ron WT, Liu YQ, Song FF, Yu SQ.
    Nanotechnology; 2012 Dec 14; 23(49):495103. PubMed ID: 23149859
    [Abstract] [Full Text] [Related]

  • 5. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations.
    Ahmad N, Alam MA, Ahmad R, Umar S, Jalees Ahmad F.
    J Microencapsul; 2018 Jun 14; 35(4):327-343. PubMed ID: 29873288
    [Abstract] [Full Text] [Related]

  • 6. Nanoparticle delivery of an SN38 conjugate is more effective than irinotecan in a mouse model of neuroblastoma.
    Iyer R, Croucher JL, Chorny M, Mangino JL, Alferiev IS, Levy RJ, Kolla V, Brodeur GM.
    Cancer Lett; 2015 May 01; 360(2):205-12. PubMed ID: 25684664
    [Abstract] [Full Text] [Related]

  • 7. MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery.
    Sayari E, Dinarvand M, Amini M, Azhdarzadeh M, Mollarazi E, Ghasemi Z, Atyabi F.
    Int J Pharm; 2014 Oct 01; 473(1-2):304-15. PubMed ID: 24905777
    [Abstract] [Full Text] [Related]

  • 8. Dual 7-ethyl-10-hydroxycamptothecin conjugated phospholipid prodrug assembled liposomes with in vitro anticancer effects.
    Du Y, Zhang W, He R, Ismail M, Ling L, Yao C, Fu Z, Li X.
    Bioorg Med Chem; 2017 Jun 15; 25(12):3247-3258. PubMed ID: 28465086
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy.
    Gao Z, Li Z, Yan J, Wang P.
    Drug Des Devel Ther; 2017 Jun 15; 11():2595-2604. PubMed ID: 28919710
    [Abstract] [Full Text] [Related]

  • 11. Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: in vitro and in vivo studies.
    Zhang H, Wang J, Mao W, Huang J, Wu X, Shen Y, Sui M.
    J Control Release; 2013 Mar 10; 166(2):147-58. PubMed ID: 23266448
    [Abstract] [Full Text] [Related]

  • 12. Solid lipid nanoparticles containing 7-ethyl-10-hydroxycamptothecin (SN38): Preparation, characterization, in vitro, and in vivo evaluations.
    Mosallaei N, Mahmoudi A, Ghandehari H, Yellepeddi VK, Jaafari MR, Malaekeh-Nikouei B.
    Eur J Pharm Biopharm; 2016 Jul 10; 104():42-50. PubMed ID: 27108266
    [Abstract] [Full Text] [Related]

  • 13. Polymeric nanoparticles of siRNA prepared by a double-emulsion solvent-diffusion technique: Physicochemical properties, toxicity, biodistribution and efficacy in a mammary carcinoma mice model.
    Ben David-Naim M, Grad E, Aizik G, Nordling-David MM, Moshel O, Granot Z, Golomb G.
    Biomaterials; 2017 Nov 10; 145():154-167. PubMed ID: 28863309
    [Abstract] [Full Text] [Related]

  • 14. Novel lipophilic SN38 prodrug forming stable liposomes for colorectal carcinoma therapy.
    Xing J, Zhang X, Wang Z, Zhang H, Chen P, Zhou G, Sun C, Gu N, Ji M.
    Int J Nanomedicine; 2019 Nov 10; 14():5201-5213. PubMed ID: 31371956
    [Abstract] [Full Text] [Related]

  • 15. Biotin decorated PLGA nanoparticles containing SN-38 designed for cancer therapy.
    Mehdizadeh M, Rouhani H, Sepehri N, Varshochian R, Ghahremani MH, Amini M, Gharghabi M, Ostad SN, Atyabi F, Baharian A, Dinarvand R.
    Artif Cells Nanomed Biotechnol; 2017 May 10; 45(3):495-504. PubMed ID: 27137460
    [Abstract] [Full Text] [Related]

  • 16. SN-38 active loading in poly(lactic-co-glycolic acid) nanoparticles and assessment of their anticancer properties on COLO-205 human colon adenocarcinoma cells.
    Essa S, Daoud J, Lafleur M, Martel S, Tabrizian M.
    J Microencapsul; 2015 May 10; 32(8):784-93. PubMed ID: 26381056
    [Abstract] [Full Text] [Related]

  • 17. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y, Pan J, Feng SS.
    Int J Pharm; 2010 Aug 16; 395(1-2):243-50. PubMed ID: 20472049
    [Abstract] [Full Text] [Related]

  • 18. Novel disulfide bond bridged 7-ethyl-10-hydroxyl camptothecin-undecanoic acid conjugate/human serum albumin nanoparticles for breast cancer therapy.
    Zhang Y, Wang J, Liu C, Xing H, Jiang Y, Li X.
    J Mater Chem B; 2023 Mar 15; 11(11):2478-2489. PubMed ID: 36843543
    [Abstract] [Full Text] [Related]

  • 19. BR2 and CyLoP1 enhance in-vivo SN38 delivery using pegylated PAMAM dendrimers.
    Mahmoudi A, Jaafari MR, Ramezanian N, Gholami L, Malaekeh-Nikouei B.
    Int J Pharm; 2019 Jun 10; 564():77-89. PubMed ID: 30991135
    [Abstract] [Full Text] [Related]

  • 20. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
    Kim TH, Jiang HH, Youn YS, Park CW, Tak KK, Lee S, Kim H, Jon S, Chen X, Lee KC.
    Int J Pharm; 2011 Jan 17; 403(1-2):285-91. PubMed ID: 21035530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.